Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society of Rheumatology
Methodological detailsnarrative review of the literature, expert consensus, Narrative review and assessment of methodological strength of evidence on cardiovascular (CV) risk assessment in rheumatoid arthritis (RA); results shared with the CORDIS steering committee; unanimously agreed-upon algorithm discussed and approved by the experts
- Narrative review of the literature
- Expert consensus
- Narrative review and assessment of methodological strength of evidence on CV risk assessment in RA; results shared with the CORDIS steering committee; unanimously agreed-upon algorithm discussed and approved by the experts
Recommendations
As issued by the authors
Monitor CV profile with the Italian 'Progetto Cuore' chart, per current EULAR recommendations for CV risk management, at least every 5 years
Consider a more stringent CV risk assessment with high disease activity, multi-drug failure, prolonged GC and/or NSAID treatment, or concomitant hypertension, dyslipidaemia or diabetes mellitus
With moderate CV risk, measure intima-media thickening
High CV risk requires a cardiological evaluation
Original publication
Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society of Rheumatology. Clin Exp Rheumatol. Published 28 August 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →